MedPath

Ofloxacin

Generic Name
Ofloxacin
Brand Names
Ocuflox
Drug Type
Small Molecule
Chemical Formula
C18H20FN3O4
CAS Number
82419-36-1
Unique Ingredient Identifier
A4P49JAZ9H

Overview

A synthetic fluoroquinolone (fluoroquinolones) antibacterial agent that inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Background

A synthetic fluoroquinolone (fluoroquinolones) antibacterial agent that inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Indication

For the treatment of infections (respiratory tract, kidney, skin, soft tissue, UTI), urethral and cervical gonorrhoea.

Associated Conditions

  • Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB)
  • Acute Otitis Media (AOM)
  • Bacterial Infections
  • Cervicitis
  • Community Acquired Pneumonia (CAP)
  • Complicated Urinary Tract Infection
  • Conjunctivitis
  • Epididymitis
  • Hansen's Disease
  • Nongonococcal urethritis
  • Otitis Externa
  • Prostatitis
  • Skin and Subcutaneous Tissue Bacterial Infections
  • Spontaneous Bacterial Peritonitis (SBP)
  • Traveler's Diarrhea
  • Ulcerative keratitis
  • Acute Pelvic inflammatory disease
  • Acute, uncomplicated Gonorrhea
  • Chronic suppurative Otitis media
  • Uncomplicated Cystitis

FDA Approved Products

Ofloxacin Otic
Manufacturer:RPK Pharmaceuticals, Inc.
Route:AURICULAR (OTIC)
Strength:3 mg in 1 mL
Approved: 2022/11/17
NDC:53002-2604
OFLOXACIN
Manufacturer:Leading Pharma, LLC
Route:AURICULAR (OTIC)
Strength:0.2 mg in 1 mL
Approved: 2024/03/23
NDC:69315-320
Ofloxacin
Manufacturer:Amneal Pharmaceuticals NY LLC
Route:AURICULAR (OTIC)
Strength:3 mg in 1 mL
Approved: 2023/05/11
NDC:69238-1615
ofloxacin
Manufacturer:NuCare Pharmceuticals,Inc.
Route:AURICULAR (OTIC)
Strength:3 mg in 1 mL
Approved: 2023/01/06
NDC:68071-2910
Ofloxacin
Manufacturer:American Regent, Inc.
Route:OPHTHALMIC
Strength:3 mg in 1 mL
Approved: 2010/07/08
NDC:0517-0761

Singapore Approved Products

FUGACIN TABLET 200 mg
Manufacturer:SHIN POONG PHARMACEUTICAL CO LTD
Form:TABLET, FILM COATED
Strength:200 mg
Online:Yes
Approved: 1995/10/26
Approval:SIN08409P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath